Literature DB >> 34543006

Critical Evaluation of Different Lysosomal Labeling Methods Used to Analyze RNA Nanocarrier Trafficking in Cells.

Shoaib Iqbal1, Benjamin Luo1, Jilian R Melamed1, Emily S Day1,2,3.   

Abstract

The use of nucleic acids to regulate gene expression is a rapidly developing field with immense clinical potential. Nanomaterials are frequently used to deliver nucleic acids into cells as they can overcome the poor cellular uptake and endo/lysosomal degradation of bare nucleic acids. For these nanocarriers to be effective, they must escape endo/lysosomal compartments to deliver their nucleic acid cargo into the cytosol (for ribonucleic acid (RNA)) or nucleus (for deoxyribonucleic acid (DNA)). This process is poorly understood and remains an area of active research toward the goal of developing effective delivery strategies. Fluorescent endo/lysosomal markers are among the most widely employed tools used to evaluate the endosomal escape of nucleic acid nanocarriers. However, the endo/lysosomal labeling method may alter the extent of and route of nanocarrier uptake by cells. The impact of these markers on cellular function and cell-nanocarrier interactions has not been probed in a systematic manner. To investigate this, we compared the effects of several common lysosomal labeling methods, namely, LysoTracker Red (LT Red), transient lysosomal-associated membrane protein 1-mutant green fluorescent protein (LAMP1-mGFP) transfection (Transient GFP), and stable lentiviral LAMP1-mGFP transfection (Stable GFP), on cellular metabolic activity, nanocarrier uptake, nanocarrier/lysosomal label colocalization, and gene silencing potency in U87 glioblastoma and MDA-MB-231 breast cancer cells using polyethyleneimine (PEI)/ribonucleic acid (RNA) polyplexes as a model nanocarrier. In both U87s and MDA-MB-231s, Transient GFP and LT Red labeling reduced metabolic activity relative to untransfected (Parental) cells, while Stable GFP labeling increased metabolic activity. Congruently, flow cytometry indicates Stable GFP cells have greater polyplex uptake than LT Red-labeled cells in both cell lines. Despite these similar trends in uptake, polyplex intracellular trafficking differs in the two cell lines, as confocal imaging revealed greater polyplex/lysosome colocalization in Stable GFP U87 cells than LT Red-labeled U87 cells, while the trend was reversed in MBA-MB-231s. The level of RNA-mediated gene silencing achieved in Parental versus Stable GFP U87 and MDA-MB-231 cells agreed with the observed levels of polyplex/lysosome colocalization, supporting the established concept that endosomal escape is the rate-limiting step for RNA interference. These findings indicate that lysosomal labels can profoundly alter cellular function and cell-nanocarrier interactions, presenting critical new considerations for researchers investigating nanoparticle trafficking.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34543006      PMCID: PMC9014481          DOI: 10.1021/acs.bioconjchem.1c00405

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   6.069


  55 in total

1.  Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice.

Authors:  Ayumi Sato; Motoki Takagi; Akira Shimamoto; Shigeru Kawakami; Mitsuru Hashida
Journal:  Biomaterials       Date:  2006-12-04       Impact factor: 12.479

2.  A high content assay to assess cellular fitness.

Authors:  Christophe Antczak; Jeni P Mahida; Chanpreet Singh; Paul A Calder; Hakim Djaballah
Journal:  Comb Chem High Throughput Screen       Date:  2014-01       Impact factor: 1.339

3.  Evaluating the Mechanisms of Light-Triggered siRNA Release from Nanoshells for Temporal Control Over Gene Regulation.

Authors:  Rachel S Riley; Megan N Dang; Margaret M Billingsley; Baxter Abraham; Lars Gundlach; Emily S Day
Journal:  Nano Lett       Date:  2018-05-02       Impact factor: 11.189

4.  Evaluation of acridine orange, LysoTracker Red, and quinacrine as fluorescent probes for long-term tracking of acidic vesicles.

Authors:  Agnieszka Pierzyńska-Mach; Paweł A Janowski; Jurek W Dobrucki
Journal:  Cytometry A       Date:  2014-06-20       Impact factor: 4.355

Review 5.  Non-viral vectors for gene-based therapy.

Authors:  Hao Yin; Rosemary L Kanasty; Ahmed A Eltoukhy; Arturo J Vegas; J Robert Dorkin; Daniel G Anderson
Journal:  Nat Rev Genet       Date:  2014-07-15       Impact factor: 53.242

6.  Disturbed cholesterol traffic but normal proteolytic function in LAMP-1/LAMP-2 double-deficient fibroblasts.

Authors:  Eeva-Liisa Eskelinen; Christine Katrin Schmidt; Silja Neu; Marion Willenborg; Graciela Fuertes; Natalia Salvador; Yoshitaka Tanaka; Renate Lüllmann-Rauch; Dieter Hartmann; Jörg Heeren; Kurt von Figura; Erwin Knecht; Paul Saftig
Journal:  Mol Biol Cell       Date:  2004-04-30       Impact factor: 4.138

7.  Gene silencing by gold nanoshell-mediated delivery and laser-triggered release of antisense oligonucleotide and siRNA.

Authors:  Ryan Huschka; Aoune Barhoumi; Qing Liu; Jack A Roth; Lin Ji; Naomi J Halas
Journal:  ACS Nano       Date:  2012-08-13       Impact factor: 15.881

8.  Cancer-selective nanoparticles for combinatorial siRNA delivery to primary human GBM in vitro and in vivo.

Authors:  Kristen L Kozielski; Alejandro Ruiz-Valls; Stephany Y Tzeng; Hugo Guerrero-Cázares; Yuan Rui; Yuxin Li; Hannah J Vaughan; Marissa Gionet-Gonzales; Casey Vantucci; Jayoung Kim; Paula Schiapparelli; Rawan Al-Kharboosh; Alfredo Quiñones-Hinojosa; Jordan J Green
Journal:  Biomaterials       Date:  2019-04-12       Impact factor: 12.479

9.  Polymeric Engineering of Nanoparticles for Highly Efficient Multifunctional Drug Delivery Systems.

Authors:  Beatrice Fortuni; Tomoko Inose; Monica Ricci; Yasuhiko Fujita; Indra Van Zundert; Akito Masuhara; Eduard Fron; Hideaki Mizuno; Loredana Latterini; Susana Rocha; Hiroshi Uji-I
Journal:  Sci Rep       Date:  2019-02-25       Impact factor: 4.379

10.  Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity.

Authors:  Kathryn A Whitehead; J Robert Dorkin; Arturo J Vegas; Philip H Chang; Omid Veiseh; Jonathan Matthews; Owen S Fenton; Yunlong Zhang; Karsten T Olejnik; Volkan Yesilyurt; Delai Chen; Scott Barros; Boris Klebanov; Tatiana Novobrantseva; Robert Langer; Daniel G Anderson
Journal:  Nat Commun       Date:  2014-06-27       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.